Fondaparinux for Prevention of Venous Thromboembolism in High-Risk Trauma Patients: A Pilot Study

Abstract

Fondaparinux appears to offer protection against VTE in high-risk trauma patients. Its once-daily dosing regimen can improve compliance and reduce cost and eliminate risk of heparin-induced thrombocytopenia.